Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy
2010

How SIRT3 Helps Prevent Heart Problems as We Age

Sample size: 19 publication 10 minutes Evidence: high

Author Information

Author(s): Hafner Angela V., Dai Jing, Gomes Ana P., Xiao Chun-Yang, Palmeira Carlos M., Rosenzweig Anthony, Sinclair David A.

Primary Institution: Harvard Medical School, Department of Pathology and Glenn Labs for Aging Research

Hypothesis

SIRT3 might increase cell survival by regulating a mitochondrial protein that dictates cell viability.

Conclusion

SIRT3 activity is necessary to prevent mitochondrial dysfunction and cardiac hypertrophy during aging.

Supporting Evidence

  • SIRT3 knockout mice show accelerated signs of aging in the heart including cardiac hypertrophy and fibrosis at 13 months of age.
  • SIRT3 activity prevents mitochondrial dysfunction and cardiac hypertrophy during aging.
  • Half of the SIRT3−/− mice died in the first 20 days following the TAC procedure, whereas none of the wild-type mice died.
  • SIRT3 delays age-related changes in the heart, including increased left ventricular thickness and cardiac fibrosis.

Takeaway

SIRT3 is a protein that helps keep our heart healthy as we get older by preventing damage to our heart cells.

Methodology

Mice were subjected to cardiac stress induced by transverse aortic constriction and monitored for cardiac hypertrophy and survival.

Limitations

The study focused only on the heart and did not explore other tissues that may also be affected by SIRT3.

Participant Demographics

Mice, specifically wild-type and SIRT3 knockout strains.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication